1 study found for:    7986716 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
Condition: Myelodysplastic Syndrome
Intervention: Drug: Panhematin

Indicates status has not been verified in more than two years